Saeed A. Qureshi

FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms

Martin Siewert, Jennifer Dressman, Cynthia K. Brown et al. · AAPS PharmSciTech · 2003 · 365 citations · Full text

Novel/special Dosage Forms, Preclinical Drug Evaluation, Fip/aaps Guidelines +9

Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators.

Janardan K. Reddy, Narendra D. Lalwani, M. K. Reddy et al. · PubMed · 1982 · 181 citations

Pathology, Persistent Proliferation, Toxicological Mechanism +19

Evaluation of Selected Hypolipidemic Agents for the Induction of Peroxisomal Enzymes and Peroxisome Proliferation in the Rat Liver

Narendra D. Lalwani, M. K. Reddy, Saeed A. Qureshi et al. · Human Toxicology · 1983 · 135 citations

Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed [4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14, 643) in the semipurified diet

Narendra D. Lalwani, M. K. Reddy, Saeed A. Qureshi et al. · Carcinogenesis · 1981 · 99 citations

Lipid Peroxidation, Pathology, Fatty Liver Disease +19

Cause of high variability in drug dissolution testing and its impact on setting tolerances

Saeed A. Qureshi, Javad Shabnam · European Journal of Pharmaceutical Sciences · 2001 · 88 citations

Medicine, Drug Dissolution Testing, High Variability +8